The Role of a Tertiary Level Safety Net Hospital in New York City's 2022 Mpox Outbreak

Similar to the early phases of the COVID-19 pandemic, New York City was the national epicenter of the ongoing 2022 mpox (formerly monkeypox) outbreak. Cases quickly began to rise in July 2022, primarily in gay, bisexual, or other men who have sex with men. Tools in the form of a reliable diagnostic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Health security 2023-04, Vol.21 (2), p.146-155
Hauptverfasser: Lo Piccolo, Anthony J, Wallach, Andrew, McPherson, Tristan D, Mgbako, Ofole, Fagan, Ian, Pitts, Robert A, Klinger, Amanda, Foote, Mary, Garcia, Elizabeth A, Zucker, Jason E, Chan, Justin, Bails, Douglas B, Cohen, Gabriel M, Tennill, Patricia Ann, Wong, Marcia, Mukherjee, Vikramjit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Similar to the early phases of the COVID-19 pandemic, New York City was the national epicenter of the ongoing 2022 mpox (formerly monkeypox) outbreak. Cases quickly began to rise in July 2022, primarily in gay, bisexual, or other men who have sex with men. Tools in the form of a reliable diagnostic test, an effective vaccine, and a viable treatment option have been available from the onset, although logistically complex to roll out. The special pathogens program at NYC Health + Hospitals/Bellevue, the flagship facility for the largest public hospital system in the United States, collaborated with multiple departments within Bellevue, the hospital system, and the NYC Department of Health and Mental Hygiene, to swiftly establish ambulatory testing, immunizations, patient-centered inpatient care, and outpatient therapeutics. With the ongoing mpox outbreak, hospitals and local health departments must prepare a systemwide response to identify and isolate patients and provide high-quality care. Findings from our experience can help guide institutions in developing a multipronged, comprehensive response to the ongoing mpox outbreak.
ISSN:2326-5094
2326-5108
DOI:10.1089/hs.2022.0120